Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
Enantioselective total synthesis of the highly selective sphingosine-1-receptor VPC01091 by the Heck desymmetrization of a non-activated cyclopentene-fused spiro-pyrrolidinone.
KIR4.1: K(+) Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis.
Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.
Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorates Long-Term Cognitive Impairments Caused by Neonatal Hypoxia-Ischemia in Rats.
Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo.
Vascular, glial, and lymphatic immune gateways of the central nervous system.
Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.
Sphingosine-1-phosphate modulators in inflammatory skin diseases-Lining up for clinical translation.
Suspected Acoustic Neuroma Demyelinating Lesions.
Children with multiple sclerosis should not become therapeutic hostages.
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation.
Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons.
Regarding the past, what is the trial you have always been dreaming of in CIDP?
How long does it take to diagnose patients with neuromyelitis optica (NMO) using the 2006 diagnostic criteria?
Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.
A case of chronic inflammatory demyelinating polyradiculoneuropathy after treatment with pegylated interferon α-2a in a patient with chronic hepatitis B virus infection.
A Post-stroke Therapeutic Regimen with Omega-3 Polyunsaturated Fatty Acids that Promotes White Matter Integrity and Beneficial Microglial Responses after Cerebral Ischemia.
Imaging of Central Nervous System Demyelinating Disorders.
Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia.
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.
Neutrophils and viral-induced neurologic disease.
Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
Whole Exome Sequencing Identifies the Genetic Basis of Late-Onset Leigh Syndrome in a Patient with MRI but Little Biochemical Evidence of a Mitochondrial Disorder.
Pages
« first
‹ previous
…
838
839
840
841
842
843
844
845
846
…
next ›
last »